← Intelligence Vault
ingredientsExpert Opinion3 min read

PEG-400-Modified transethosomes for resveratrol Delivery: Enhanced dermal penetration and collagen remodeling over Dermarolling Strategies.

Authors · Zoweil M, Aboushady D, Kamel AS et al.
Journal · Eur J Pharm Biopharm · August 2026
What this means for you

The plain-language read

The uncoated vesicles demonstrated high stability and uniformity, with a size of 320. 1% hyaluronic acid (HA), successful surface functionalization and improved size stability was achieved. Ex vivo and confocal studies confirmed that these PEG-liposomes successfully reached the deep dermis; notably, a sequential application strategy of the coated and uncoated PEG-liposomes showed that uncoated vesicles could transiently disrupt lipid structures to facilitate deeper penetration for the HA-coated versions.

Key findings
  • By coating these vesicles with 0.1% hyaluronic acid (HA), successful surface functionalization and improved size stability was achieved.
  • The uncoated vesicles demonstrated high stability and uniformity, with a size of 320.17 ± 0.25 nm and a zeta potential of -35.2 ± 0.4 mV.
  • Ex vivo and confocal studies confirmed that these PEG-liposomes successfully reached the deep dermis; notably, a sequential application strategy of the coated and uncoated PEG-liposomes showed that uncoated vesicles could transiently disrupt lipid structures to facilitate deeper penetration for the HA-coated versions.
  • The cooperative effect of this dual-vesicle system not only restored the structural integrity of the dermal-epidermal junction but also significantly outperformed existing commercial resveratrol products.
Practical note

Relevant if you're working with hyaluronic acid, resveratrol, pha for aging.

Translate to action

What this means for your routine

hyaluronic_acidAM/PM routine0.1%

If you're targeting aging, this research supports adding hyaluronic_acid to your AM/PM routine. Effective concentration range: 0.1% based on this study.

resveratrolAM/PM routine0.1%

If you're targeting aging, this research supports adding resveratrol to your AM/PM routine. Effective concentration range: 0.1% based on this study.

Translated from this study's findings, not a personal prescription. Pair with your existing protocol and your practitioner's guidance.

Technical Summary, For Professional Reference

Clinical context

1. Eur J Pharm Biopharm. 2026 Aug 5:115206. doi: 10.1016/j.ejpb.2026.115206. Online ahead of print. PEG-400-Modified transethosomes for resveratrol Delivery: Enhanced dermal penetration and collagen remodeling over Dermarolling Strategies.

Full abstract

1. Eur J Pharm Biopharm. 2026 Aug 5:115206. doi: 10.1016/j.ejpb.2026.115206. Online ahead of print. PEG-400-Modified transethosomes for resveratrol Delivery: Enhanced dermal penetration and collagen remodeling over Dermarolling Strategies. Zoweil M(1), Aboushady D(2), Kamel AS(3), Tadros MI(4), Mansour S(5), Rady M(6). Author information: (1)Department Pharmaceutical Technology, Faculty of Pharmacy and Biotechnology, German University in Cairo, 11865, New Cairo, Egypt; Department of Pharmaceutics, Faculty of Pharmacy and Drug Technology, Chinese University, 11771 Cairo, Egypt. (2)Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo 11856, New Cairo, Egypt. (3)Department of Pharmacology and Toxicology, Faculty of Pharmacy and Drug Technology, Chinese University, 11771 Cairo, Egypt; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, 11562 Cairo, Egypt. (4)Department of Pharmaceutics, Faculty of Pharmacy and Drug Technology, Chinese University, 11771 Cairo, Egypt; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, 11562 Cairo, Egypt. (5)Department Pharmaceutical Technology, Faculty of Pharmacy and Biotechnology, German University in Cairo, 11865, New Cairo, Egypt; Department Pharmaceutical Technology, Faculty of Pharmaceutical Engineering, German International University, 11841, New Administrative Capital, New Cairo, Egypt; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy Ain Shams University, 11566 Cairo, Egypt. (6)Department Pharmaceutical Technology, Faculty of Pharmacy and Biotechnology, German University in Cairo, 11865, New Cairo, Egypt; Department Pharmaceutical Technology, Faculty of Pharmaceutical Engineering, German International University, 11841, New Administrative Capital, New Cairo, Egypt. Electronic address: mairady48@gmail.com. Skin aging is a complex biological process driven by collagen degradation and oxidative damage, often exacerbated by UV exposure. While resveratrol is a premier antioxidant for anti-aging, its topical efficacy is historically limited by poor water solubility and weak skin penetration. This study addresses these barriers by developing optimized polyethylene glycol-based liposomes (PEG-liposomes) as novel deformable liposome derivative. The uncoated vesicles demonstrated high stability and uniformity, with a size of 320.17 ± 0.25 nm and a zeta potential of -35.2 ± 0.4 mV. By coating these vesicles with 0.1% hyaluronic acid (HA), successful surface functionalization and improved size stability was achieved. Ex vivo and confocal studies confirmed that these PEG-liposomes successfully reached the deep dermis; notably, a sequential application strategy of the coated and uncoated PEG-liposomes showed that uncoated vesicles could transiently disrupt lipid structures to facilitate deeper penetration for the HA-coated versions. When integrated with micro-needling via a derma roller, the system triggered significant collagen remodeling and a surge in antioxidant enzymes like SOD, while simultaneously reducing oxidative stress markers such as MDA, MMP-1, and the aging indicator beta-galactosidase. The cooperative effect of this dual-vesicle system not only restored the structural integrity of the dermal-epidermal junction but also significantly outperformed existing commercial resveratrol products. Our findings demonstrate that this novel PEG-liposomal system provides a transformative approach to deep-tissue rejuvenation. Through its unique synergistic mechanism with micro-needling, it achieves biological remodeling and dermal restoration that surpasses the efficacy of current market-leading standards. Copyright © 2026. Published by Elsevier B.V. DOI: 10.1016/j.ejpb.2026.115206 PMID: 42556752 Conflict of interest statement: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Original source →
Related research
ingredientsSystematic Review

Does Astragalus mongholicus Bunge help promote the healing of wounds? A systematic review and meta-analysis of preclinical animal studies.

Front Pharmacol · Jan 2026

Wounds continue to represent a significant public health challenge globally. In recent years, Astragalus mongholicus Bunge, a traditional Chinese botanical drug utilized for wound treatment, has garnered increasing research attention. However, the therapeutic efficacy and safety of this natural botanical drug on wound healing remain poorly understood.

phacollagensystematic_review
Read →
ingredientsRCT

Safety and efficacy of individualised exercise and NAD(+) precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.

Lancet Neurol · May 2026

Friedreich's ataxia is a rare, chronic, progressive, neurodegenerative condition affecting multiple organ systems, including neurological, musculoskeletal, cardiac, and endocrine systems, and is marked by low cardiopulmonary fitness. We tested the effect of exercise and NAD+ precursor supplementation with nicotinamide riboside, which have each shown benefits in animal and early clinical studies, on cardiopulmonary fitness in individuals with Friedreich's ataxia. This 12-week, outpatient, phase 2, single-site (Children's Hospital of Philadelphia, Philadelphia, PA, USA), randomised, 2 × 2 factorial clinical trial recruited individuals aged 10-40 years with an ejection fraction of 45% or greater who were able to exercise.

niacinamidepharct
Read →
regulationOpinion

Multitargeted Modulation of Skin Dullness by HNHT Formulation: Synergistic Inhibition of Melanogenesis, Glycation, and Lipofuscin Deposition.

J Cosmet Dermatol · May 2026

Skin dullness, characterized by pigmentation disorders and yellowing, is a major cosmetic concern in Asian populations. Lipofuscin exhibits ultraviolet (UV)/visible light spectral absorption, reduces skin reflectance, and contributes to dullness, whereas existing therapies targeting melanogenesis and glycation lack comprehensive efficacy. This study aimed to evaluate the multimodal anti-dullness effects of a novel formulation (HNHT: hyaluronic acid, niacinamide, hydrolyzed red algae, and tranexamic acid).

niacinamidehyaluronic_acidtranexamic_acid
Read →

This information is for educational purposes only and is not medical advice. Individual results vary. Consult a qualified dermatologist or healthcare professional for medical concerns. Full disclaimer →